# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-013256
Filing Date
2025-04-10
Accepted
2025-04-10 16:11:20
Documents
7
Period of Report
2025-05-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20044910x3_def14a.htm | DEF 14A | 380891
2 |  | logo_plustherapeutics1.jpg | GRAPHIC | 33360
3 |  | ny20044910x3_internet.jpg | GRAPHIC | 5735
4 |  | ny20044910x3_mail.jpg | GRAPHIC | 6660
5 |  | ny20044910x3_pc01.jpg | GRAPHIC | 958217
6 |  | ny20044910x3_pc02.jpg | GRAPHIC | 685948
7 |  | ny20044910x3_phone.jpg | GRAPHIC | 6434
| Complete submission text file | 0001140361-25-013256.txt |  | 2717221

Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 25828524
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)